What is the average price of teicoplanin exports from India?

The average unit price for teicoplanin exports from India is $1030.74 USD per unit, with prices ranging from $0.01 to $17574.11 depending on formulation, packaging, and order volume. The total market is valued at $6.3M across 310 shipments.

Which ports handle teicoplanin exports from India?

The primary ports for teicoplanin exports from India are SAHAR AIR CARGO ACC (INBOM4) (22.3% of shipments), SAHAR AIR (21.6% of shipments), NHAVA SHEVA SEA (INNSA1) (8.7% of shipments), DELHI AIR (7.7% of shipments), Bombay Air (7.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Why is India a leading exporter of teicoplanin?

India is one of the world's leading exporters of teicoplanin due to its large base of 60 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports teicoplanin to 44 countries, demonstrating 23% global market coverage.

What certifications do Indian teicoplanin exporters need?

Indian teicoplanin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

How many buyers import teicoplanin from India?

There are 108 registered buyers importing teicoplanin from India, spread across 44 countries. The repeat buyer rate is 62.0%, indicating strong long-term trade relationships and consistent product quality.

What is the market share of the top teicoplanin supplier from India?

GUFIC BIOSCIENCES LIMITED is the leading teicoplanin exporter from India with a market share of 71.8% and total export value of $4.5M across 87 shipments. The top 5 suppliers together control 90.3% of total export value.

Teicoplanin

India Pharmaceutical Trade Intelligence

$6.3M60 Suppliers44 CountriesHS 30042099

ExportsIndia → HUNGARY35.6%India → SRI LANKA18.4%

ImportsITALY → India$65.9B FRANCE → India$517.3K

#1 Supplier: GUFIC BIOSCIENCES

Teicoplanin Export Data from India (2026) — Suppliers, Buyers & Trade Stats | TransData Nexus | TransData Nexus

How India Exports Teicoplanin to the World

Q: Who are the top teicoplanin exporters from India?

The top teicoplanin exporters from India are: 1. GUFIC BIOSCIENCES LIMITED — $4.5M (71.8% market share); 2. FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED — $445.3K (7.1% market share); 3. JODAS EXPOIM PRIVATE LIMITED — $272.1K (4.3% market share); 4. CIPLA LIMITED — $234.7K (3.7% market share); 5. NEON LABORATORIES LIMITED — $215.1K (3.4% market share). Together they account for 90.3% of India's total teicoplanin export value.

Q: What is the total export value of teicoplanin from India?

The total export value of teicoplanin from India is $6.3M USD, recorded across 310 shipment transactions from 60 active exporters to 44 destination countries. The average shipment value is $20.3K.

Q: Which countries import teicoplanin from India?

India exports teicoplanin to 44 countries worldwide. The top importing countries are: HUNGARY (35.6% share, $2.2M), SRI LANKA (18.4% share, $1.2M), SOUTH AFRICA (17.9% share, $1.1M), CUBA (5.4% share, $338.0K), GERMANY (5.4% share, $336.9K). These five markets account for 82.6% of total export value.

Q: What is the HS code for teicoplanin exports from India?

The primary HS code for teicoplanin exports from India is 30042099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Between 2022 and 2026, India exported $6.3M worth of teicoplanin across 310 verified shipments to 44 countries — covering 23% of world markets in the Advanced Antibiotics segment. The largest destination is HUNGARY (35.6%). GUFIC BIOSCIENCES LIMITED leads with a 71.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Teicoplanin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Teicoplanin export data snapshot — $6.3M · 60 exporters · 44 countriesTransData Nexus · Indian Customs Data

Top Teicoplanin Exporters from India

60 active exporters · Ranked by export value

View all 60 →

Top Teicoplanin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GUFIC BIOSCIENCES LIMITED	$4.5M	87	8	71.8%
2	FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED

Top Countries Importing Teicoplanin from India

44 destination markets · Ranked by import value

All 44 countries →

Top Countries Importing Teicoplanin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	HUNGARY	$2.2M	35.6%
2	SRI LANKA	$1.2M	18.4%
3	SOUTH AFRICA	$1.1M	17.9%
4	CUBA	$338.0K	5.4%
5	GERMANY	$336.9K	5.4%
6	RUSSIA	$272.1K	4.3%
7	LEBANON	$215.0K	3.4%
8	NEPAL	$152.3K	2.4%
9	VENEZUELA	$121.7K	1.9%
10	SPAIN	$105.6K	1.7%

HUNGARY is India's largest teicoplanin export destination, absorbing 35.6% of total exports worth $2.2M. The top 5 importing countries — HUNGARY, SRI LANKA, SOUTH AFRICA, CUBA, GERMANY — together account for 82.6% of India's total teicoplanin export value. The remaining 39 destination countries collectively receive the other 17.4%, indicating a focused distribution strategy targeting key markets.

Who Supplies Teicoplanin to India?

4 origin countries · Total import value: $65.9B

India imports teicoplanin from 4 countries with a combined import value of $65.9B. The largest supplier is ITALY ($65.9B, 40 shipments), followed by FRANCE and SINGAPORE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Teicoplanin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ITALY	$65.9B	40	100.0%
2	FRANCE	$517.3K	5	0.0%
3	SINGAPORE	$470.0K	2	0.0%
4	BRAZIL	$413	2	0.0%

ITALY is the largest supplier of teicoplanin to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Teicoplanin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book does not list any approved Abbreviated New Drug Applications (ANDAs) for teicoplanin, indicating the absence of generic versions in the U.S. market. In May 2018, the FDA granted orphan drug designation to Neupharma S.r.l. for teicoplanin for the treatment of Staphylococcus aureus lung infections in patients with cystic fibrosis. However, this designation does not equate to marketing approval. The lack of approved ANDAs suggests that Indian exporters may face challenges entering the U.S. market, potentially due to regulatory hurdles or limited market demand.

2EU & UK Regulatory Framework

In the European Union, teicoplanin is marketed under the brand name Targocid by Sanofi-Aventis. In May 2013, the European Medicines Agency (EMA) completed a review of Targocid, leading to harmonized prescribing information across EU member states. Additionally, in August 2017, the EMA granted orphan designation to Neupharma S.r.l. for teicoplanin for the treatment of cystic fibrosis. This designation aims to encourage the development of medicines for rare diseases. Compliance with EU Good Manufacturing Practice (GMP) standards is mandatory for manufacturers exporting to the EU and UK markets.

3WHO Essential Medicines & Global Standards

Teicoplanin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating serious bacterial infections. The antibiotic is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, teicoplanin is classified under Schedule H of the Drugs and Cosmetics Rules, 1945, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for teicoplanin, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the export of critical pharmaceuticals.

5Patent & Exclusivity Status

Teicoplanin's primary patents have expired, leading to increased generic competition globally. This competitive landscape is reflected in India's export market, where 60 active exporters have engaged in teicoplanin shipments between 2022 and 2026.

6Recent Industry Developments

In August 2022, the EMA published a list of nationally authorized medicinal products containing teicoplanin, following a periodic safety update report (PSUR) single assessment. This assessment led to variations in marketing authorizations to enhance safety information. In January 2021, the EMA's Committee for Medicinal Products for Human Use (CHMP) concluded a PSUR single assessment for teicoplanin, resulting in updated product information to reflect new safety data. These regulatory activities highlight the ongoing monitoring and updating of teicoplanin's safety profile within the EU.

Overall, while teicoplanin maintains a significant presence in global markets, particularly in the EU and select countries, its absence in the U.S. market and the competitive export environment from India underscore the importance of strategic regulatory navigation and market analysis for stakeholders.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Teicoplanin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Teicoplanin, heavily relies on Key Starting Materials (KSMs) sourced from China. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved Active Pharmaceutical Ingredients (APIs) are solely sourced from China, while 16% come exclusively from India. This dependency poses significant risks, as any disruption in the supply of these critical materials can halt API production, leading to shortages of essential medications.

Recent geopolitical tensions have exacerbated these vulnerabilities. In February 2026, the closure of the Strait of Hormuz due to military conflicts disrupted the supply of raw materials to Asia's petrochemical industry, affecting the availability of essential chemicals for pharmaceutical manufacturing. Such disruptions underscore the fragility of supply chains dependent on concentrated sources for critical inputs.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in Teicoplanin exports from India. The top five exporters account for 90.3% of the total export value, with GUFIC BIOSCIENCES LIMITED alone contributing 71.8%. This concentration heightens the risk of supply disruptions, as issues affecting a single supplier can have disproportionate impacts on the global availability of Teicoplanin.

Access Complete Teicoplanin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 310 transactions across 44 markets.

Request Demo View Pricing

Frequently Asked Questions — Teicoplanin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top teicoplanin exporters from India?

The leading teicoplanin exporters from India are GUFIC BIOSCIENCES LIMITED, FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED, and 8 others. GUFIC BIOSCIENCES LIMITED leads with 71.8% market share ($4.5M). The top 5 suppliers together control 90.3% of total export value.

What is the total export value of teicoplanin from India?

The total export value of teicoplanin from India is $6.3M, recorded across 310 shipments from 60 active exporters to 44 countries. The average shipment value is $20.3K.

Which countries import teicoplanin from India?

India exports teicoplanin to 44 countries. The top importing countries are HUNGARY (35.6%), SRI LANKA (18.4%), SOUTH AFRICA (17.9%), CUBA (5.4%), GERMANY (5.4%), which together account for 82.6% of total export value.

What is the HS code for teicoplanin exports from India?

The primary HS code for teicoplanin exports from India is 30042099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Teicoplanin

Teicoplanin

How India Exports Teicoplanin to the World

Top Teicoplanin Exporters from India

Top Countries Importing Teicoplanin from India

Who Supplies Teicoplanin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Teicoplanin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Teicoplanin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Teicoplanin Trade Intelligence

Frequently Asked Questions — Teicoplanin Exports from India

Who are the top teicoplanin exporters from India?

What is the total export value of teicoplanin from India?

Which countries import teicoplanin from India?

What is the HS code for teicoplanin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of teicoplanin exports from India?

Which ports handle teicoplanin exports from India?

Why is India a leading exporter of teicoplanin?

What certifications do Indian teicoplanin exporters need?

How many buyers import teicoplanin from India?

What is the market share of the top teicoplanin exporter from India?

Analysis Methodology